<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Engrossed-in-House" dms-id="H78264E0EBDB5490E8553E91EAE869866" public-private="public" key="H" bill-type="olc" stage-count="1"> 
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>117 HR 3630 EH: Lymphedema Treatment Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date></dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="no">I</distribution-code> 
<congress display="yes">117th CONGRESS</congress><session display="yes">2d Session</session> 
<legis-num display="yes">H. R. 3630</legis-num> 
<current-chamber display="no">IN THE HOUSE OF REPRESENTATIVES</current-chamber> 
<legis-type>AN ACT</legis-type> 
<official-title display="yes">To amend title XVIII of the Social Security Act to provide for coverage of certain lymphedema compression treatment items under the Medicare program.</official-title> 
</form> 
<legis-body id="HCAC5EB151D7E47DA9A57E107D58FAAFA" style="OLC"> 
<section id="H1A90D76553114003A4D8254FEA14E2CF" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Lymphedema Treatment Act</short-title></quote>. </text></section> <section id="HEE57B51287E140BA973CD723739914D3"><enum>2.</enum><header>Medicare coverage of certain lymphedema compression treatment items</header> <subsection id="HEDEE1F8845F24E8C96413754412BFEA1"><enum>(a)</enum><header>Coverage</header> <paragraph id="H2DE21B6EFC0B46DE92F7448ACDA30284"><enum>(1)</enum><header>In general</header><text display-inline="yes-display-inline">Section 1861 of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395x">42 U.S.C. 1395x</external-xref>) is amended—</text> 
<subparagraph id="H8579EC2D9B494137AD591E7DF146A4D6"><enum>(A)</enum><text>in subsection (s)(2)—</text> <clause id="HE12960637F9B42ECA8F773D76A525A78"><enum>(i)</enum><text>in subparagraph (GG), by striking <quote>and</quote> after the semicolon at the end;</text></clause> 
<clause id="HE7C549827E634153BDDAEF847FC5C008"><enum>(ii)</enum><text>in subparagraph (HH), by striking the period at the end and inserting <quote>; and</quote>; and</text></clause> <clause id="HA9171D3DB3954F1084F4E8B9D3839219"><enum>(iii)</enum><text>by adding at the end the following new subparagraph:</text> 
<quoted-block display-inline="no-display-inline" id="HE56313BEE5DC4976AFA5810B77BB2A61" style="OLC"> 
<subparagraph id="HB376D3D6413A472A871262757E36437A" indent="up1"><enum>(II)</enum><text display-inline="yes-display-inline">lymphedema compression treatment items (as defined in subsection (lll));</text></subparagraph><after-quoted-block>; and</after-quoted-block></quoted-block></clause></subparagraph> <subparagraph id="H3EE80F259AEC456E9B126136506937AE"><enum>(B)</enum><text>by adding at the end the following new subsection:</text> 
<quoted-block style="OLC" id="HDE7C1545B7574BC288106F593FF5E976" display-inline="no-display-inline"> 
<subsection id="H36D8D8AC0785475597D885B338848234"><enum>(lll)</enum><header>Lymphedema compression treatment items</header><text display-inline="yes-display-inline">The term <term>lymphedema compression treatment items</term> means standard and custom fitted gradient compression garments and other items determined by the Secretary that are—</text> <paragraph id="H5D1D0530F2B74B5780FCE8DA109EF3A3"><enum>(1)</enum><text display-inline="yes-display-inline">furnished on or after January 1, 2024, to an individual with a diagnosis of lymphedema for the treatment of such condition;</text></paragraph> 
<paragraph id="H6D8B6836A358481985ABD05EF72D0F49"><enum>(2)</enum><text>primarily and customarily used to serve a medical purpose and for the treatment of lymphedema, as determined by the Secretary; and</text></paragraph> <paragraph id="HA71D122BFAE141EA85316F8F9979E834"><enum>(3)</enum><text>prescribed by a physician (or a physician assistant, nurse practitioner, or a clinical nurse specialist (as those terms are defined in section 1861(aa)(5)) to the extent authorized under State law).</text></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block></subparagraph></paragraph> 
<paragraph id="H199164C3251745C7B156BA0684F4A25A"><enum>(2)</enum><header>Payment</header> 
<subparagraph id="H85B0CDF5B7D44F99BCB2AE07E49A256A"><enum>(A)</enum><header>In general</header><text display-inline="yes-display-inline">Section 1833(a)(1) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395l">42 U.S.C. 1395l(a)(1)</external-xref>) is amended—</text> <clause id="H768E01024C5949628A5176E87401DDE5"><enum>(i)</enum><text>by striking <quote>, and</quote> before <quote>(EE)</quote>; and</text></clause> 
<clause id="HCC1077A6F0CC4646959678729839E7AD"><enum>(ii)</enum><text>by inserting before the semicolon at the end the following: <quote>, and (FF) with respect to lymphedema compression treatment items (as defined in section 1861(lll)), the amount paid shall be equal to 80 percent of the lesser of the actual charge or the amount determined under the payment basis determined under section 1834(z)</quote>.</text></clause></subparagraph> <subparagraph id="HCB76D3877C634448AB486F84E7AEAB54"><enum>(B)</enum><header>Payment basis and limitations</header><text>Section 1834 of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395m">42 U.S.C. 1395m</external-xref>) is amended by adding at the end the following new subsection:</text> 
<quoted-block style="OLC" id="H039F14E5A0C24F87867DDD527704D2FF" display-inline="no-display-inline"> 
<subsection id="H00EDAC4B537B447CAF5B1EC708E99B77"><enum>(z)</enum><header>Payment for lymphedema compression treatment items</header> 
<paragraph id="H34B79B273C5741F192E85DA6C692E542"><enum>(1)</enum><header>In general</header><text display-inline="yes-display-inline">The Secretary shall determine an appropriate payment basis for lymphedema compression treatment items (as defined in section 1861(lll)). In making such a determination, the Secretary may take into account payment rates for such items under State plans (or waivers of such plans) under title XIX, the Veterans Health Administration, and group health plans and health insurance coverage (as such terms are defined in section 2791 of the Public Health Service Act), and such other information as the Secretary determines appropriate.</text></paragraph> <paragraph id="H296870F3C76B44399C54AE7909EB2342"><enum>(2)</enum><header>Frequency limitation</header><text>No payment may be made under this part for lymphedema compression treatment items furnished other than at such frequency as the Secretary may establish.</text></paragraph> 
<paragraph id="HDE8B4E374716441892D39A2AB40D2D18"><enum>(3)</enum><header>Application of competitive acquisition</header><text>In the case of lymphedema compression treatment items that are included in a competitive acquisition program in a competitive acquisition area under section 1847(a)—</text> <subparagraph id="H8098C5BB45A743AF9B4C100543AF0F2D"><enum>(A)</enum><text display-inline="yes-display-inline">the payment basis under this subsection for such items furnished in such area shall be the payment basis determined under such competitive acquisition program; and</text></subparagraph> 
<subparagraph id="HE615CCE8BB43462696FF26CD01A06CDA"><enum>(B)</enum><text display-inline="yes-display-inline">the Secretary may use information on the payment determined under such competitive acquisition programs to adjust the payment amount otherwise determined under this subsection for an area that is not a competitive acquisition area under section 1847, and in the case of such adjustment, paragraphs (8) and (9) of section 1842(b) shall not be applied.</text></subparagraph></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block></subparagraph></paragraph> <paragraph id="H7F8396ED22DF46C4A44CE3C97AC6C865"><enum>(3)</enum><header>Conforming amendment</header><text display-inline="yes-display-inline">Section 1847(a)(2) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-3">42 U.S.C. 1395w–3(a)(2)</external-xref>) is amended by adding at the end the following new subparagraph:</text> 
<quoted-block style="OLC" id="HCFA8D09FA6B44F79B3606DCD12530FA6" display-inline="no-display-inline"> 
<subparagraph id="HCF130D92490442E688F404FEAA48EB93"><enum>(D)</enum><header>Lymphedema compression treatment items</header><text display-inline="yes-display-inline">Lymphedema compression treatment items (as defined in section 1861(lll)) for which payment would otherwise be made under section 1834(z). </text></subparagraph><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></subsection> <subsection id="HDCFBC4E29BDF478CAFC70D76FBC44DE5"><enum>(b)</enum><header>Inclusion in requirements for suppliers of medical equipment and supplies</header><text>Section 1834 of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395m">42 U.S.C. 1395m</external-xref>) is amended—</text> 
<paragraph id="HCDD5314CB5A14A61AD335F41D17F87E5"><enum>(1)</enum><text>in subsection (a)(20)(D), by adding at the end the following new clause:</text> <quoted-block style="OLC" id="H6EFFCB2D4B4440B3B84243CB7462C640" display-inline="no-display-inline"> <clause id="HE525329EF83248DA9A8EF5EB6CB3ABBD"><enum>(iv)</enum><text display-inline="yes-display-inline">Lymphedema compression treatment items (as defined in section 1861(lll)).</text></clause><after-quoted-block>.</after-quoted-block></quoted-block></paragraph> 
<paragraph id="H32ED7383FCB54E2FADD72524EFCDA839"><enum>(2)</enum><text>in subsection (j)(5)—</text> <subparagraph id="H39552D4F60BF4CFC98ED2C923CB7D08D"><enum>(A)</enum><text>by redesignating subparagraphs (E) and (F) as subparagraphs (F) and (G), respectively; and</text></subparagraph> 
<subparagraph id="H105DCA82779A44959B21F806B79BA802"><enum>(B)</enum><text>by inserting after subparagraph (D) the following new subparagraph:</text> <quoted-block style="OLC" id="HD887FF4D787A45BC8BF91261D91B390A" display-inline="no-display-inline"> <subparagraph id="H02E0AAEE4CC34AACA0E9BA48D7A0E61D"><enum>(E)</enum><text display-inline="yes-display-inline">lymphedema compression treatment items (as defined in section 1861(lll));</text></subparagraph><after-quoted-block>.</after-quoted-block></quoted-block></subparagraph></paragraph></subsection></section> 
<section id="H4070CB4534D84D73AC57708A1572CE0B"><enum>3.</enum><header>Medicare Improvement Fund</header><text display-inline="no-display-inline">Section 1898(b)(1) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395iii">42 U.S.C. 1395iii(b)(1)</external-xref>) is amended by striking <quote>$7,308,000,000</quote> and inserting <quote>$6,738,000,000</quote>.</text></section> <section id="HFFF187C1E1D74C7B97FBA3EE1C3DD158"><enum>4.</enum><header>Determination of budgetary effects</header><text display-inline="no-display-inline">The budgetary effects of this Act, for the purpose of complying with the Statutory Pay-As-You-Go Act of 2010, shall be determined by reference to the latest statement titled <quote>Budgetary Effects of PAYGO Legislation</quote> for this Act, submitted for printing in the Congressional Record by the Chairman of the House Budget Committee, provided that such statement has been submitted prior to the vote on passage. </text></section> 
</legis-body> <attestation><attestation-group><attestation-date date="20221115" chamber="House">Passed the House of Representatives November 17, 2022.</attestation-date><attestor display="no">Cheryl L. Johnson,</attestor><role>Clerk.</role></attestation-group></attestation> 
<endorsement display="yes"></endorsement> 
</bill> 


